Determining the association of thrombophilic gene polymorphisms with recurrent pregnancy loss in Iranian women

References

• Ji J, Zhai H, Zhou H, et al. The role and mechanism of vitamin D‐mediated regulation of Treg/Th17 balance in recurrent pregnancy loss. Am J Reprod Immunol. 2019;81(6):e13112.
   PubMed Web of Science ®Google Scholar
• Kamali M, Hantoushzadeh S, Borna S, et al. Association between thrombophilic genes polymorphisms and recurrent pregnancy loss susceptibility in the Iranian population: a systematic review and meta-analysis. Iran Biomed J. 2018;22(2):78–89.
   PubMedGoogle Scholar
• Rajcan-Separovic E. Next generation sequencing in recurrent pregnancy loss-approaches and outcomes. Eur J Med Genet. 2020;63(2):103644.
   PubMed Web of Science ®Google Scholar
• Egerup P, Kolte A, Larsen E, et al. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses? Hum Reprod. 2016;31(11):2428–2434.
   PubMed Web of Science ®Google Scholar
• Wingeyer SP, Aranda F, Udry S, et al. Inherited thrombophilia and pregnancy loss. Study of an Argentinian cohort. Med Clín (English Ed.). 2019;152(7):249–254.
   PubMed Web of Science ®Google Scholar
• Plasín-Rodríguez MA, Rodríguez-Pintó I, Patricio P, et al. The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome. Thromb Res. 2018;169:128–134.
   PubMed Web of Science ®Google Scholar
• Jiang J, Liu K, Zou J, et al. Associations between polymorphisms in coagulation-related genes and venous thromboembolism: a meta-analysis with trial sequential analysis. Medicine. 2017;96(13):e6537.
   PubMed Web of Science ®Google Scholar
• Li Y-y, Wu J-j, Yang X-x, et al. EPCR gene Ser219Gly polymorphism and venous thromboembolism: a meta-analysis of 9,494 subjects. Front Physiol. 2017;8:339.
   PubMed Web of Science ®Google Scholar
• Gailani D, Gruber A. Factor XI as a therapeutic target. Arterioscler Thromb Vasc Biol. 2016;36(7):1316–1322.
   PubMed Web of Science ®Google Scholar
• Sennblad B, Basu S, Mazur J, et al. Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor XI levels. Hum Mol Genet. 2017;26(3):637–649.
   PubMed Web of Science ®Google Scholar
• Barlik M, Seremak-Mrozikiewicz A, Drews K, et al. Correlation between factor VII and PAI-1 genetic variants and recurrent miscarriage. Ginekol Pol. 2016;87(7):504–509.
   PubMed Web of Science ®Google Scholar
• Dendana M, Messaoudi S, Hizem S, et al. Endothelial protein C receptor 1651C/G polymorphism and soluble endothelial protein C receptor levels in women with idiopathic recurrent miscarriage. Blood Coagul Fibrinolysis. 2012;23(1):30–34.
   PubMed Web of Science ®Google Scholar
• Galanaud J, Cochery‐Nouvellon E, Alonso S, et al. Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy. J. Thromb Haemost. 2010;8(4):707–713.
   PubMed Web of Science ®Google Scholar
• Cochery-Nouvellon E, Chauleur C, Demattei C, et al. The A6936G polymorphism of the endothelial protein C receptor gene is associated with the risk of unexplained foetal loss in Mediterranean European couples. Thromb Haemost. 2009;102(10):656–667.
   PubMedGoogle Scholar
• Franchi F, Biguzzi E, Cetin I, et al. Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss. Br J Haematol. 2001;114(3):641–646.
   PubMed Web of Science ®Google Scholar
• Reiner AP, Carty CL, Jenny NS, et al. PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study. J Thromb Haemost. 2008;6(10):1625–1632.
   PubMed Web of Science ®Google Scholar
• Yamagishi K, Cushman M, Heckbert SR, et al. Lack of association of soluble endothelial protein C receptor and PROCR 6936A/G polymorphism with the risk of venous thromboembolism in a prospective study. Br J Haematol. 2009;145(2):221–226.
   PubMed Web of Science ®Google Scholar
• Ireland HA, Cooper JA, Drenos F, et al. FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy men. ATVB. 2009;29(11):1968–1974.
   Google Scholar
• Tang W, Basu S, Kong X, et al. Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study. Blood. 2010;116(23):5032–5036.
   PubMed Web of Science ®Google Scholar
• Sokol J, Biringer K, Skerenova M, et al. Activity of coagulation factor XI in patients with spontaneous miscarriage: the presence of risk alleles. J Obstet Gynaecol. 2015;35(6):621–624.
   PubMedGoogle Scholar
• Yue Y, Sun Q, Man C, et al. Association of the CYP4V2 polymorphism rs13146272 with venous thromboembolism in a Chinese population. Clin Exp Med. 2019;19(1):159–166.
   PubMed Web of Science ®Google Scholar
• Rovite V, Maurins U, Megnis K, et al. Association of F11 polymorphism rs2289252 with deep vein thrombosis and related phenotypes in population of Latvia. Thromb Res. 2014;134(3):659–663.
   PubMed Web of Science ®Google Scholar
• Li Y, Bezemer I, Rowland C, et al. Genetic variants associated with deep vein thrombosis: the F11 locus. J Thromb Haemost. 2009;7(11):1802–1808.
   PubMed Web of Science ®Google Scholar
• Austin H, De Staercke C, Lally C, et al. New gene variants associated with venous thrombosis: a replication study in White and Black Americans. J Thromb Haemost. 2011;9(3):489–495.
   PubMed Web of Science ®Google Scholar
• Delluc A, Gourhant L, Lacut K, et al. Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control study. Thromb Haemost. 2010;103(6):1161–1169.
   PubMed Web of Science ®Google Scholar
• Bezemer ID, Bare LA, Doggen CJ, et al. Gene variants associated with deep vein thrombosis. JAMA. 2008;299(11):1306–1314.
   PubMed Web of Science ®Google Scholar
• Smith NL, Hindorff LA, Heckbert SR, et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA. 2007;297(5):489–498.
   PubMed Web of Science ®Google Scholar
• Bernardi F, Arcieri P, Bertina R, et al. Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations. Arterioscler Thromb Vasc Biol. 1997;17(11):2548–2553.
   PubMed Web of Science ®Google Scholar
• Moor E, Silveira A, van’t Hooft F, et al. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age: role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol. 1995;15(5):655–664.
   PubMed Web of Science ®Google Scholar
• Olson N, Raffield L, Lange L, et al. Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk. J Thromb Haemost. 2018;16(1):19–30.
   PubMed Web of Science ®Google Scholar